FADS2 and lung carcinoma: To further validate these findings, 10 lung cancer tissue samples (5 radioresistant and 5 radiosensitive) were collected, and IHC analysis showed significantly lower FADS2 expression in radioresistant tissues compared to radiosensitive tissues (Figure 9E, 9F).